Akanda Corp. (AKAN) vs Petros Pharmaceuticals, Inc. (PTPI)

Akanda Corp. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $2.4M against $1.0M — 2.3× the size. Across the 7 metrics below, Akanda Corp. leads on 5 and Petros Pharmaceuticals, Inc. on 2.

Valuation

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S n/m n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 0.34 2.56
Earnings yield — 0.00% (2.99%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Gross margin — 76.35% 53.94%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (710.28%) (0.40%)
Return on assets 0.00% (334.15%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 36.07% 10.01%
EPS growth (last fiscal year) (139.63%) 98.13% —
Revenue growth, 5-year CAGR 44.20% (19.98%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Debt to equity (1.08) 0.00 0.05
Current ratio 0.58 1.25 2.31
Net debt to EBITDA (2.75) 1.11 0.85

Dividend

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKAN PTPI Drug Manufacturers Specialty & Generic median
Market cap 2.44m 1.04m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack